Coronavirus: Mexico to conduct phase 3 trials for China, U.S. vaccine candidates

MEXICO CITY — Mexico will conduct late-stage clinical trials for COVID-19 vaccines in development by Johnson & Johnson and two Chinese companies, the foreign ministry said on Tuesday.

Large-scale, phase three human testing for the J&J unit Janssen Pharmaceuticals’s candidate could start in the second half of September, the company has previously said.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Mexico will also help test candidates for Chinese companies Cansino Biologics Inc and Walvax Biotechnology Co Ltd, the ministry said in a presentation at a news conference.

Story continues below advertisement

© 2020 Reuters

Read The Full Article At Global News. This content is provided by Global News at public RSS feed. Please contact us if you have any questions.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.